Opportunity Information: Apply for RFA AG 20 007
The NIH funding opportunity "Characterization of Marmosets as Models of Aging and Age-Related Diseases (U34 Clinical Trial Not Allowed)" (RFA-AG-20-007) is a discretionary, health-focused cooperative agreement intended to accelerate the development and validation of the common marmoset as a laboratory animal model for studying aging biology and age-related diseases. The central purpose is not to run human clinical studies, but to build the foundational scientific and operational groundwork needed so that marmosets can be used more consistently, rigorously, and informatively in aging research. In practical terms, the FOA is aimed at supporting planning and preparatory activities that help the research community understand how marmosets age, what normal aging looks like in this species, what measurements are reliable and reproducible, and how age-associated conditions can be detected and tracked in ways that are relevant to human aging.
This opportunity uses the cooperative agreement mechanism (U34), which generally signals substantial scientific or programmatic involvement from NIH staff compared with a traditional investigator-initiated grant. The intent is typically to support structured planning, protocol development, and coordination activities that can lead to stronger, more standardized future research efforts. Because the FOA is explicitly labeled "Clinical Trial Not Allowed," applications are expected to stay on the non-clinical-trial side of NIH policy, meaning they should not propose studies designed to prospectively assign human participants to an intervention in order to evaluate health-related outcomes. The focus here is on preclinical and model-development work centered on marmosets.
The program sits under the NIH, with an associated CFDA number of 93.866, and the activity category is listed as Health. The award ceiling is $225,000, indicating a modest budget consistent with planning, characterization, standardization, and preliminary infrastructure-type activities rather than large-scale, multi-year experimental programs. The original closing date for applications was October 22, 2019, and the FOA creation date was June 14, 2019. The number of expected awards is not specified in the provided listing, which often means it may vary depending on application quality, program priorities, and available funds.
A wide range of domestic applicant organizations are eligible. These include state, county, and city governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; certain tribal organizations; nonprofits with or without 501(c)(3) status (other than higher education institutions); for-profit organizations other than small businesses; and small businesses. The FOA also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. This broad eligibility is meant to encourage participation from many institutional types, including those that serve underrepresented communities and those with specialized research or animal-resource capabilities.
At the same time, there are clear restrictions on foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. Non-domestic components of U.S. organizations are also not eligible, and foreign components (as NIH defines them in its Grants Policy Statement) are not allowed. In effect, the work supported under this FOA must be carried out within eligible U.S.-based institutional structures without foreign components, which simplifies oversight and aligns with NIH policy and program goals for this specific initiative.
Overall, this FOA is best understood as a targeted NIH effort to strengthen the scientific foundation for using marmosets in aging and age-related disease research. By supporting coordinated characterization work, the program aims to make marmoset-based studies more interpretable and comparable across labs, improve the quality of aging-related phenotyping and measurement, and ultimately help the broader research ecosystem assess when and how this primate model can responsibly and effectively inform human aging and disease mechanisms.Apply for RFA AG 20 007
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Characterization of Marmosets as Models of Aging and Age-Related Diseases (U34 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2019-06-14.
- Applicants must submit their applications by 2019-10-22. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $225,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Undergraduate Research Education Program (UP) to Enhance Diversity in the Environmental Health Sciences (R25 Clinical Trial Not Allowed)
Previous opportunity: The Electronic Medical Records and Genomics (eMERGE): Genomic Risk Assessment and Management Network - Clinical Sites (U01 Clinical Trial Required)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AG 20 007
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AG 20 007) also looked into and applied for these:
| Funding Opportunity |
|---|
| Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional) Apply for PAR 19 298 Funding Number: PAR 19 298 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Institute of General Medical Sciences (NIGMS) Bridges to the Baccalaureate (T34) Apply for PAR 19 299 Funding Number: PAR 19 299 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Country Health Information Systems and Data Use (CHISU) Apply for 7200AA19R00065 Funding Number: 7200AA19R00065 Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (T32) Apply for PAR 19 300 Funding Number: PAR 19 300 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Centers for Cryoelectron Tomography (U24 - Clinical Trial Not Allowed) Apply for RFA RM 19 009 Funding Number: RFA RM 19 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Service Network Hub for Cryoelectron Tomography (U24 - Clinical Trial Not Allowed) Apply for RFA RM 19 010 Funding Number: RFA RM 19 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Lipid Signaling in Healthspan and Longevity Regulation (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 039 Funding Number: RFA AG 20 039 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) Apply for PAR 19 302 Funding Number: PAR 19 302 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) Apply for PAR 19 301 Funding Number: PAR 19 301 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) Apply for RFA AG 20 018 Funding Number: RFA AG 20 018 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Implementation Research on Hypertension Control to Prevent Dementia and Cognitive Decline (R61/R33 Clinical Trial Optional) Apply for RFA AG 20 028 Funding Number: RFA AG 20 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional) Apply for PAR 19 304 Funding Number: PAR 19 304 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional) Apply for PAR 19 305 Funding Number: PAR 19 305 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimers Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 042 Funding Number: RFA AG 20 042 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Computational Methods for Integrating Tissue and Single Cell Genomic Data from the Brain (R01 Clinical Trial Not Allowed) Apply for RFA MH 20 300 Funding Number: RFA MH 20 300 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Child Neurologist Career Development Program (CNCDP) (K12 Clinical Trial Not Allowed) Apply for RFA NS 19 040 Funding Number: RFA NS 19 040 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed) Apply for PAR 19 307 Funding Number: PAR 19 307 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed) Apply for RFA AG 20 020 Funding Number: RFA AG 20 020 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Transition to Aging Research for Predoctoral Students (F99/K00) Apply for RFA AG 20 009 Funding Number: RFA AG 20 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA AG 20 021 Funding Number: RFA AG 20 021 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AG 20 007", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
